Janney Montgomery Scott
FLNA

Janney Montgomery Scott’s Filana Therapeutics FLNA Stock Holding History

Janney Montgomery Scott’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,690
Closed -$298K – 2790
2024
Q1 		$298K Buy
14,690
+506
+4% +$11.7K ﹤0.01% 2348
2023
Q4 		$319K Sell
14,184
-10,040
-41% -$212K ﹤0.01% 2178
2023
Q3 		$403K Buy
24,224
+3,796
+19% +$75.2K ﹤0.01% 1939
2023
Q2 		$501K Buy
20,428
+6,463
+46% +$156K ﹤0.01% 1865
2023
Q1 		$337K Buy
13,965
+693
+5% +$19.2K ﹤0.01% 1981
2022
Q4 		$392K Sell
13,272
-31
-0.2% -$1.11K ﹤0.01% 1933
2022
Q3 		$556K Buy
+13,303
New +$359K ﹤0.01% 1642
2022
Q2 		– Sell
-12,486
Closed -$464K – 2420
2022
Q1 		$464K Buy
12,486
+2,153
+21% +$91.2K ﹤0.01% 1664
2021
Q4 		$452K Buy
10,333
+3,140
+44% +$165K ﹤0.01% 1783
2021
Q3 		$447K Buy
7,193
+21
+0.3% +$1.75K ﹤0.01% 1725
2021
Q2 		$613K Buy
7,172
+87
+1% +$4.66K ﹤0.01% 1518
2021
Q1 		$318K Buy
+7,085
New +$279K ﹤0.01% 1822

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Janney Montgomery Scott's FLNA Position: Q2 2024 in Review

Janney Montgomery Scott sold out of Filana Therapeutics (FLNA) in Q2 2024, closing a stake of 14,690 shares — an estimated $298K sold.

Janney Montgomery Scott first reported a position in FLNA in Q1 2021 and held it in 12 quarters. The position peaked at $613K in Q2 2021. 145 funds tracked by Wall St. Rank hold FLNA as of Q2 2024.

  • Janney Montgomery Scott reported no remaining Filana Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Janney Montgomery Scott sold 14,690 Filana Therapeutics shares in Q2 2024, an estimated $298K.
  • Janney Montgomery Scott first reported a position in Filana Therapeutics in Q1 2021 and held it in 12 quarters.
  • Janney Montgomery Scott's Filana Therapeutics position peaked at $613K in Q2 2021.
  • 145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2024.

Based on Janney Montgomery Scott's 13F filing for Q2 2024, filed 25 Jul 2024.